mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.2 |
2e-05 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-05 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
7e-05 |